A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

August 31, 2011

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Acarbose (Glucobay ODT, BAYG5421)

Day 1: oral sucrose load (75 g sucrose dissolved in 225 mL water) without Glucobay ODT; Day 2: oral sucrose load plus Glucobay ODT taken without water

DRUG

Acarbose (Glucobay ODT, BAYG5421)

Day 1: oral sucrose load (75 g sucrose dissolved in 225 mL water) without Glucobay ODT; Day 2: oral sucrose load plus Glucobay ODT taken with water

DRUG

Acarbose (Glucobay, BAYG5421)

Day 1: oral sucrose load (75 g sucrose dissolved in 225 mL water) without Glucobay standard tablet; Day 2: oral sucrose load plus Glucobay standard tablet taken with water

Trial Locations (1)

41061

Mönchengladbach

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY